HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simona Ruggieri Selected Research

Simona Ruggieri Research Topics

Disease

20Neoplasms (Cancer)
03/2020 - 05/2013
6Multiple Myeloma
07/2018 - 08/2013
3Breast Neoplasms (Breast Cancer)
04/2018 - 10/2016
2Glioblastoma (Glioblastoma Multiforme)
10/2019 - 10/2014
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2019 - 01/2019
2Stomach Neoplasms (Stomach Cancer)
08/2018 - 11/2017
2Adenocarcinoma
11/2017 - 10/2017
2Anemia
02/2014 - 10/2013
1Inflammation (Inflammations)
09/2019
1Fibrosarcoma
09/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2019
1Cognitive Dysfunction
01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Monoclonal Gammopathy of Undetermined Significance
07/2018
1Prostatic Neoplasms (Prostate Cancer)
10/2017
1Endometrial Neoplasms (Endometrial Cancer)
02/2017
1Macular Degeneration (Age-Related Maculopathy)
10/2016
1Triple Negative Breast Neoplasms
10/2016
1Glioma (Gliomas)
10/2014
1Astrocytoma (Pilocytic Astrocytoma)
10/2014
1Meningioma (Meningiomas)
10/2014
1Paraproteinemias (Monoclonal Gammopathy)
02/2014
1Kidney Diseases (Kidney Disease)
10/2013
1Plasmacytoma
08/2013
1Necrosis
08/2013
1Osteoarthritis
06/2013
1Osteoporosis
06/2013
1Bone Diseases (Bone Disease)
06/2013
1Melanoma (Melanoma, Malignant)
05/2013
1Uveitis
08/2012
1Lymphoma (Lymphomas)
03/2012

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
01/2019 - 05/2013
5Tryptases (Tryptase)IBA
04/2018 - 08/2016
4ErythropoietinFDA Link
01/2019 - 10/2013
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2019 - 05/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019 - 06/2013
3Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2014
2apo-dystrophin 1IBA
10/2019 - 01/2019
2Protein Isoforms (Isoforms)IBA
10/2019 - 01/2019
2DystrophinIBA
10/2019 - 01/2019
2Bortezomib (Velcade)FDA Link
02/2014 - 08/2013
1Biomarkers (Surrogate Marker)IBA
03/2020
1PTX3 proteinIBA
09/2019
1Complement C3 (C3 Complement)IBA
09/2019
1Pharmaceutical PreparationsIBA
03/2019
1Angiogenesis InhibitorsIBA
03/2019
1Bevacizumab (Avastin)FDA Link
01/2019
1OligonucleotidesIBA
08/2018
1Monoclonal AntibodiesIBA
08/2018
1RNA (Ribonucleic Acid)IBA
08/2018
1Transcription Factors (Transcription Factor)IBA
04/2018
1Chymases (Chymase)IBA
11/2017
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2017
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2017
1NestinIBA
05/2017
1Peptide Hydrolases (Proteases)FDA Link
02/2017
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2016
1ProgesteroneFDA LinkGeneric
10/2016
1Estrogens (Estrogen)FDA Link
10/2016
1Caspase 3 (Caspase-3)IBA
10/2014
1ParaffinIBA
10/2014
1Formaldehyde (Formol)FDA Link
10/2014
1Messenger RNA (mRNA)IBA
02/2014
1Lenalidomide (CC 5013)FDA Link
02/2014
1((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
08/2013
1Culture MediaIBA
06/2013
1Cholecalciferol (Vitamin D3)FDA Link
06/2013
1AntibodiesIBA
05/2013
1MART-1 AntigenIBA
05/2013

Therapy/Procedure

8Therapeutics
07/2019 - 08/2012
2Lasers (Laser)
05/2017 - 03/2012
1Drug Therapy (Chemotherapy)
01/2019
1Neoadjuvant Therapy
01/2019
1Nephrectomy
01/2019